BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31417870)

  • 1. A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer.
    He R; Zuo S
    Front Oncol; 2019; 9():693. PubMed ID: 31417870
    [No Abstract]   [Full Text] [Related]  

  • 2. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
    Wang K; Li Y; Wang J; Chen R; Li J
    Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer.
    Lin T; Fu Y; Zhang X; Gu J; Ma X; Miao R; Xiang X; Niu W; Qu K; Liu C; Wu Q
    Aging (Albany NY); 2018 Sep; 10(9):2356-2366. PubMed ID: 30205363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
    Yang X; Wang G; Gu R; Xu X; Zhu G
    PeerJ; 2020; 8():e10418. PubMed ID: 33304656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular gene signature and prognosis of non-small cell lung cancer.
    Huang P; Cheng CL; Chang YH; Liu CH; Hsu YC; Chen JS; Chang GC; Ho BC; Su KY; Chen HY; Yu SL
    Oncotarget; 2016 Aug; 7(32):51898-51907. PubMed ID: 27437769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined eight-long noncoding RNA signature: a new risk score predicting prognosis in elderly non-small cell lung cancer patients.
    Miao R; Ge C; Zhang X; He Y; Ma X; Xiang X; Gu J; Fu Y; Qu K; Liu C; Wu Q; Lin T
    Aging (Albany NY); 2019 Jan; 11(2):467-479. PubMed ID: 30659574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma.
    Lin L; Zhang W
    Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
    Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
    Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma.
    Liu L; He H; Peng Y; Yang Z; Gao S
    PeerJ; 2021; 9():e11911. PubMed ID: 34631307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An effective prognostic model for assessing prognosis of non-small cell lung cancer with brain metastases.
    Wang R; Zhang X; He C; Guo W
    Front Genet; 2023; 14():1156322. PubMed ID: 37124617
    [No Abstract]   [Full Text] [Related]  

  • 16. A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network.
    Xie H; Xie C
    Biomed Res Int; 2019; 2019():4250613. PubMed ID: 31886214
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
    Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
    J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer.
    Miao TW; Yang DQ; Gao LJ; Yin J; Zhu Q; Liu J; He YQ; Chen X
    Front Mol Biosci; 2022; 9():942402. PubMed ID: 36052170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.